Introduction
The kidneys have several essential homeostatic functions. These functions include waste removal (NH3), fluid/electrolyte balance, metabolic blood acid-base balance, and the production/modification of hormones for blood pressure, calcium/potassium homeostasis, and red blood cell production. The renal corpuscle (filtration unit, which comprises the glomerulus and the surrounding the Bowman capsule) and tubules (reabsorption and excretion) of the kidney perform the majority of these functions.
The primary function of the kidney, filtering blood, is in part due to its unique blood flow, with high perfusion autoregulation of flow across the glomerular capillaries over a range of pressures. The kidneys receive about 20% of the cardiac output, thereby enabling the filtration of large volumes of blood. Blood flow autoregulates across the filtration capillaries (glomeruli) due to the unique arrangement of blood vessels. The glomerulus, in contrast to the majority of other capillary beds, sits between 2 arterioles; receiving blood supply from the upstream afferent arteriole, and blood exiting downstream via the efferent arterioles (E for exit). This arrangement allows precise control of glomerular flow and filtration rate via autoregulatory changes in the diameters of these resistance arterioles (vasodilation/vasoconstriction).
The primary function of the kidney is to filter blood and form urine. The histological structures of the kidney's filtering units (renal corpuscles) are crucial for this function. The renal corpuscles are located only in the kidney cortex, with about 1 million per kidney; variation by race is common. This unique filtration barrier comprises 3 histological structures: the capillary endothelium of the glomeruli, specialized cells called podocytes, and the fused basement membranes of these cells (Figure 1). This filtration barrier allows the filtration of small molecules, including water, ions, creatinine, and glucose, as well as small proteins (less than 90 kDa). This structure must prevent the filtration of large proteins present in the blood, such as albumin and immunoglobulins.
Any aberrance of this filtration barrier leads to pathological conditions. Indeed, about 90% of end-stage kidney disease is due to glomerular diseases.[1] The primary concern is that once damaged, the kidneys have limited capacity for repair. Indeed, most forms of glomerular disease develop gradually, with symptoms only appearing after a significant proportion of the kidney's functional units are damaged.
Issues of Concern
Register For Free And Read The Full Article
Search engine and full access to all medical articles
10 free questions in your specialty
Free CME/CE Activities
Free daily question in your email
Save favorite articles to your dashboard
Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Issues of Concern
Glomerular diseases are heterogeneous conditions with a wide variety of etiologies and clinical presentations, but almost universally are due to disruption of the glomerular filtration barrier. These different kidney diseases can broadly be divided into 2 syndromes based on the number of proteins passing into the filtrate (glomerular filtration rate): nephrotic and nephritic.[2] These syndromes are not diseases in themselves, but a set of symptoms, signs, and laboratory findings that suggest an underlying kidney disorder, most often involving the glomerulus. While the etiologies and pathologic changes that lead to nephrotic and nephritic syndromes are highly variable, some useful generalizations are possible.
Nephrotic syndrome is mainly due to the destruction of the podocytes (nephrOtic: think O in for podocyte, or O for protein), integral parts of the filtration barrier. Podocyte dysfunction results in significant protein loss in the urine. Nephritic syndrome, on the other hand, occurs in kidney diseases that result from disruption of the glomerular basement membrane. This pathological change is primarily due to inflammation (nephritic: think I for inflammation) and results in red blood cells passing through the filtration membrane, giving the urine a cola color (hematuria). See Figure 1: Structure of the glomerulus
Structure
The renal corpuscle consists of several histological structures (Figure 1):
Glomerulus capillaries form a central tuft of looped capillaries located in the center of the renal corpuscle. These capillaries deliver blood and create a large surface area for renal filtration. These capillaries are optimized for filtration. Blood flow is regulated over a broad range of pressures, thus keeping the glomerular filtration rate relatively constant. This regulation occurs via the capillaries' unique location between 2 resistance arterioles (afferent and efferent, think E for exit).[3] Second, they present a large porous surface area for filtration. The glomerular capillary endothelium contains small transcellular pores or fenestrations (windows) of approximately 60 nm in diameter, which cover about 20% to 50% of the endothelial surface.[4][5][6] While these pores are large, the negatively charged glycocalyx covering the luminal endothelial cell surface prevents the filtration of molecules larger than 100 nm.[4][6] Third and last, these capillaries are not embedded within a supporting intracellular matrix but are relatively "free" within the Bowman capsule. Thus, it is fitting that the term glomerulus originated from the Greek word "filter."
Intraglomerular mesangial cells physically support the glomerular capillaries and occupy the intercellular spaces underneath the basement membrane. They are generally on the opposite side of the glomerulus from the podocytes.[3] (Figure 1) Glomerular capillaries require a unique support structure because they are not surrounded by interstitial tissue. The kidneys have very few stromal cells.[3] These mesangial cells are relatively small, irregular in shape, have scant cytoplasm, and have heterochromatic and indented nuclei.[7] Both mesangial cells and their secreted extracellular matrix are collectively termed mesangium. Expansion of mesangial cells in some renal diseases results in a reduction of the filtration area and occlusion of glomerular capillaries.[4] Mesangial cells have additional functions, including contractile and phagocytic functions.[7] There is some evidence that mesangial cells can be induced to secrete erythropoietin (EPO), but it is now more widely accepted that EPO is produced by peritubular cells.[8][9][10][11][12][13] Contractility alters glomerular capillary diameter in response to changes in blood pressure, thereby fine-tuning glomerular filtration rates.[3] The phagocytic function removes protein aggregates, such as immune complexes, that lodge within the glomerular filter. Since mesangial cells secrete EPO in response to hypoxia, damage can also affect red blood cell formation and hematocrit.
Bowman capsule consists of the visceral and parietal layers (Figure 1). The inner visceral layer completely encircles the glomerular capillaries. It is comprised of specialized stellate epithelial cells termed podocytes. In contrast, the outer or parietal layer of the Bowman capsule is a single layer of simple squamous epithelium. It is into the space between these 2 layers that urine is filtered.
Podocytes serve as support for the glomerular capillaries and are part of the glomerular filtration barrier. They are large cells with euchromatic nuclei and form the visceral layer of the Bowman capsule, which is exposed to the urinary space (Figure 1). The interdigitating secondary processes of the podocytes (pedicels, or foot processes) cover and encircle much of the surface of the glomerular capillaries. These foot processes contain actin and are thought to have some contractile activity to oppose the distension of the glomerular capillaries.[14] The spaces or gaps between these interdigitating pedicels form slit pores approximately 30 to 40 nm wide.[14][15] These slits are covered by a thin membrane or slit diaphragms.[4] Podocytes have limited repair capacity but can regenerate foot processes (pedicels).[3] Pedicel loss is referred to as effacement, simplification, retraction, or fusion.[3][14]
The slit diaphragms are specialized adherens junctions with nephron and other proteins forming a zipper-like structure with small pores about the size of an albumin molecule.[14][16][4][15] The protein barrier results from sieving of the filtrate through these small pores.[16][4] In addition to the pores, a negatively charged glycocalyx covers the podocytes and slit diaphragm; the negative charges also have an important barrier function and repel negatively charged proteins such as albumin.[3][4] It bears mentioning that the slight diaphragm is only visible by electron microscopy. Whether the slit diaphragm is the primary determinant of permeability selectivity remains a topic of debate.[14]
The glomerular basement membrane is the third component of the filtration barrier, along with the capillary endothelium and podocytes (Figures 1 and 2). It is a fused basement membrane between endothelial cells and podocytes, and also provides some support to the glomerular capillaries.[5][17] Thus, it is thicker (240 to 270 nm) than other capillary basement membranes (40 to 80 nm).[4] It is a gel-like material containing an organized, fibrous, mesh-like network that forms 10-nm pores.[3][18] The primary component is type IV collagen, but it also contains other proteins, including laminin, heparan sulfate, glycoproteins, and the proteoglycans agrin and perlecan.[3][4][5] The mesh-like structure and negative charges form a molecular sieve or barrier, preventing high-molecular-weight proteins, such as albumin and globulins (antibodies), from leaving the circulation.[6] The precise role of the glomerular basement membrane in selective permeability has recently come under debate, but it is undisputedly responsible for restricting fluid flux.[4][18]
The juxtaglomerular apparatus is an important group of structures located at the entry of the capillaries in the glomerulus (Figure 1). Two of these are specialized sensory structures with feedback mechanisms that regulate glomerular blood flow and filtration rate.
- Macula densa (thicker spot) is a thickened region of the distal convoluted tubule. It is characterized by apical nuclei and tightly packed columnar cells. It responds to the salt concentration in the tubular filtrate and is part of the tubuloglomerular feedback system that regulates the glomerular filtration rate. It is important to note that the macula densa, which connects to the distal tubule, regulates the glomerulus and detects salt concentration.
- Juxtaglomerular cells (also granular cells) are specialized smooth muscles in the walls of the afferent arteriole. These cells synthesize and secrete renin in response to decreased arteriolar blood pressure, thereby activating the renin-angiotensin system to regulate blood pressure.
- Lacis cells are extraglomerular mesangial cells and are in the stalk of the glomerular tuft of capillaries.[3] They have functions similar to those of intraglomerular mesangial cells.
Function
Structure of the filtration barrier. A= Endothelial cells (pink) of fenestrated glomerular capillaries, with the label 1 depicting the fenestra or pore. B= glomerular basement membrane (purple). There are 3 layers visible under electron microscopy. They are labeled as 1= lamina rara interna, 2= lamina densa, 3= lamina rara externa. C: interdigitating podocytes endfeet with slits (blue) with labeling for 1= intracellular enzymes, 2= slits, and 3= slit diaphragms. The large arrow (orange) indicates the direction of the flow of the filtrate through the filtration barrier.
Figure 2 and Legend
This glomerular filtration barrier comprises 3 structures: the glomerular capillary endothelium, podocytes, and the fused basement membranes of these cells (Figure 2). This filtration barrier is responsible for the selective permeability of substances to the kidney based on size and charge. Small molecules (less than 10 kDa) that are not bound to plasma carrier proteins, such as water and salts, are freely filtered. With increasing molecular weight, filtration decreases until proteins larger than ~90 kDa, after which no filtration occurs.[4][14]
We should note that although albumin has a molecular weight of approximately 66 kDa and a negative charge, only 0.1% of albumin is lost in plasma.[4][14] This is because, in addition to pore sieving, negative charges are part of the filtration barrier. A net negative charge is present on the endothelial lumen, podocytes, and glomerular basement membrane, which electrostatically repels negatively charged molecules such as albumin.
The actual functional mechanism underlying glomerular filtration is a balance between hydrostatic and colloid osmotic pressures (Starling forces) across the filtration barrier. The glomerular capillary pressure forces water and salts out of the blood into the Bowman space. The colloid osmotic pressure is primarily due to albumin, which helps retain water in the capillaries. In effect, albumin binding of sodium acts as a sponge, keeping and pulling extra fluid from the body into the blood. Generally, hydrostatic pressure exceeds oncotic pressure, resulting in glomerular capillary filtration.
Another important structure in the glomerulus is the juxtaglomerular apparatus, whose components respond to increased glomerular filtration rate (GFR) and decreased blood pressure. The macula densa detects the increased GFR as an increase in salt concentration within the distal tubule filtrate. The macula densa responds by releasing vasoconstrictor substances, thereby decreasing blood flow and pressure in the afferent arteriole and thereby normalizing GFR. Decreased glomerular blood pressure is regulated by granular (or juxtaglomerular) cells, so named for the intracellular granules that store renin before its release. These cells release renin, stored in intracellular granules. Renin activates the renin-angiotensin system to restore blood pressure to normal and increase blood volume (via aldosterone-mediated water reabsorption in the tubules).
Tissue Preparation
Evaluation of glomerular histology is clinically relevant primarily in the context of renal biopsies for kidney diseases. Indications for renal biopsy are not well-established and somewhat controversial. The most common medical indication worldwide for a renal biopsy is nephrotic syndrome. In patients with chronic kidney disease and/or end-stage renal disease, renal biopsies altered the clinical approach in 31% to 57% of cases.[19] Additionally, biopsies also play a critical role in monitoring for rejection in the case of renal transplantation and the evaluation of tumors of the kidney, although the glomerulus is not as frequently the focus of those assessments
A full description of the pathologic assessment of the medical renal biopsy is beyond the scope of this review; however, a summary of pathologic findings for commonly encountered diseases is provided in Tables 1-3. For the medical student and non-pathologist physician, it is important to understand that the value of the information obtained from the biopsy is intricately linked to the quality of the biopsy technique and processing procedures employed. Therefore, the following provides a brief review of key aspects of renal biopsy processing to maximize the value of histologic evaluation.
Native kidney biopsies (as opposed to allograft biopsies) are most commonly performed percutaneously with the patient in the prone position, using a 14- to 18-gauge needle. The lower pole of the kidney is typically biopsied when no specific target is identified, and a general kidney assessment is a goal. The procedure is performed using a local anesthetic and skin lancing before inserting the needle.[20] While all procedures carry some amount of risk, modern renal biopsy practice is relatively safe. Hematuria, identified by any means, is present in slightly more than a third of patients, and 0.5% present with gross hematuria. Severe complications necessitating transfusion occur in fewer than 0.1% of cases.[21]
Comprehensive pathologic evaluation of the biopsy requires assessment with 3 modalities: light microscopy, immunofluorescence/immunohistochemistry, and transmission electron microscopy. The choice of immunofluorescence and immunohistochemistry depends on the available facilities and the pathologist’s experience. Immunofluorescence is more common in the United States, whereas immunohistochemistry is performed more frequently in Europe. Following the biopsy, the sample must be divided into 3 parts for microscopic evaluation. An experienced technician or pathologist should be present at this stage. Glomeruli are observable using a dissecting microscope. The division of the biopsy core ensures the appropriate placement of glomerular tissue in each of the 3 media.
Microscopy, Light
Light Microscopy
Transport of the portion of the biopsy bound for light microscopy can be in standard buffered formalin solution at room temperature. The tissue should be wrapped in lens paper to prevent loss during processing. Using net bags or sponges introduces artifacts that interfere with interpretation and should be avoided if possible. After fixation, the tissue is embedded in paraffin. Sectioning should be done with 2- to 4-micrometer serial sections, with multiple sections per slide. Each institution tends to have its own standardized practice for how many slides are initially prepared and which stains are performed. Standard stains include hematoxylin and eosin, periodic acid-Schiff, a silver stain, and trichrome stains.[20]
Immunofluorescent Microscopy
Immunofluorescent protocols generally call for tissue to be frozen rather than fixed. Fixation of tissue does not completely eliminate the possibility of performing immunofluorescence; however, it is not ideal. Cross-linking fixatives, such as formalin and glutaraldehyde, are excellent at preserving morphological integrity but may cross-link target antigens and introduce excessive background autofluorescence. If the biopsy is being performed near the lab doing the procedure, then the tissue can be transported in regular saline. If the sample needs to travel further, then a medium such as Michel medium is preferred. Sectioning can be performed on a cryostat using 2-4 μm sections. Again, the standard workup is institution-dependent; however, routine examination typically includes IgG, IgM, IgA, complement proteins (C3, C1q, C4), fibrin, and kappa/gamma light chains along with appropriate controls.[20]
Microscopy, Electron
Ice-cold glutaraldehyde (1-3%) is the most commonly used fixative for electron microscopy. Other fixatives, such as paraformaldehyde or formalin, can be used, but are not ideal. Standard electron microscopy procedures are carried out in accordance with the institution's protocol. Usually, a relatively thick (1 micrometer) section undergoes evaluation to select a glomerulus in the given tissue, which is then sectioned into ultra-thin slices for placement on a copper grid.[20] Ultrastructure is examined at multiple levels to assess all components of the previously discussed glomerulus.
Pathophysiology
There are several signs of glomerular dysfunction that can be used in diagnosis and to distinguish nephrotic from nephritic syndromes.
- Protein in the urine (proteinuria): This is a hallmark measure of renal disease, and the primary measure used to differentiate between nephrotic and nephritic syndromes. Protein in the urine can result from glomerular disease, which causes proteins to leak into the urine, or from a defect in protein reabsorption in the kidney tubules. Proteinuria may cause foamy urine. Generally, a very high protein concentration in the urine, or "nephrotic range" >200 mg/l, is associated with podocyte disruption, resulting in non-selective protein loss.[4] Loss of protein into the urine is typically associated with reduced protein or albumin in the blood (proteinuria or hypoalbuminemia).
- Blood in the urine (hematuria): The presence of hemoglobin from leaked red blood cells gives the urine a pink or light brown (cola-colored). This presentation is a typical symptom of nephritic syndrome, along with lower proteinuria, which is associated with nephritic syndrome attributable to a defect in the glomerular basement membrane.
- Edema: Protein loss from the blood reduces colloid oncotic pressure and increases capillary filtration, leading to excess, non-resorbed fluid accumulation within the intercellular spaces, causing swelling. This swelling due to edema is usually more noticeable in the hands, ankles, or periorbitally.
- Uremia: reduced glomerular filtration rate. Disruption of the barrier can also result in reduced filtration, leading to the accumulation of waste products. Creatinine and urea nitrogen in the blood.
Acidosis: This is beyond the scope of a discussion of the glomerulus, but it still bears mentioning. Kidney tubules are involved in metabolic acid-base homeostasis, which regulates blood pH.
Tables 1-3 and Legends
Table 1: Diseases with Nephritic syndromes. This syndrome is a set of symptoms generally attributed to inflammatory processes, and not a disease in itself. It involves disruption of the glomerular basement membrane, and common features include hypertension (salt retention), increased blood urea nitrogen (BUN), creatinine, oliguria, hematuria, and red blood cell casts. Proteinuria of less than approximately 3.5 g/day. References for diseases in table 1: Le et al 2019, First Aid for the USMLE, McGraw-Hill, pp. 583-5. Key: GBM= glomerular basement membrane, LM= light microscopy, IF= immunofluorescence, EM= electron microscopy, IgG= immunoglobulin G, C3= complement C3.
Table 2: Diseases with Nephrotic syndromes. This syndrome is also a set of symptoms and not a disease in itself. It can occur with many diseases; thus, the basis of prevention is controlling the underlying causal diseases. This syndrome is generally due to podocyte disruption, which impairs the charge barrier. This syndrome is characterized by massive proteinuria > 3.5g/day with hypoalbuminemia, hyperlipidemia, and edema.[22] Also, there is an increased risk of venous thromboembolism in adults, especially of the renal vein. Edema is due to the loss of proteins. Dyslipidemia was originally thought to be due to increased albumin metabolism in the liver, but it may now be due instead to altered lipoprotein synthesis and cholesterol transport from peripheral tissues to the liver.[23][24] Thromboembolism is due to the loss of the clotting protein antithrombin III.[24] References for diseases in table 2: Le et al 2019 First Aid for the USMLE McGraw Hill pp 583-585.[1][22][1][25][26][27][28] Key: GBM= glomerular basement membrane, LM= light microscopy, IF= immunofluorescence, EM= electron microscopy, IgG= immunoglobulin G, C3= complement C3.
Table 3: Diseases with both Nephritic-nephrotic syndromes. Severe nephritic syndrome with profound glomerular basement membrane damage, resulting in a change of the charge barrier. Nephrotic range proteinuria (>3.5 g/day) and features of nephrotic syndrome. Reference for diseases in table 3: Le et al 2019 First Aid for the USMLE McGraw Hill pp 583-5.[22][25] Key: GBM= glomerular basement membrane, LM= light microscopy, IF= immunofluorescence, EM= electron microscopy, IgG= immunoglobulin G, C3= complement C3.
Clinical Significance
Glomerular damage leads to several pathologies, described below. The pathologies are readily diagnosable using blood and urine analysis. With kidney disease, one should additionally keep homeostatic regulation of red blood cell production (hematocrit), calcium and vitamin D homeostasis, blood pressure/volume, and acid-base balance in mind.
Media
(Click Image to Enlarge)
(Click Image to Enlarge)
Filtration barrier. Histology Kidney glomerulus By M•Komorniczak -talk-, polish wikipedist.Illustration by : Michał KomorniczakThis file has been released into the Creative Commons 3.0. Attribution-ShareAlike (CC BY-SA 3.0)If you use on your website or in your publication my images (either original or modified), you are requested to give me details: Michał Komorniczak (Poland) or Michal Komorniczak (Poland).For more information, write to my e-mail address: m.komorniczak.pl@gmail.com - Own workThis W3C-unspecified vector image was created with Inkscape., CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=5743097
References
Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney international. 2007 Jun:71(12):1205-14 [PubMed PMID: 17410103]
Hebert LA, Parikh S, Prosek J, Nadasdy T, Rovin BH. Differential diagnosis of glomerular disease: a systematic and inclusive approach. American journal of nephrology. 2013:38(3):253-66. doi: 10.1159/000354390. Epub 2013 Sep 13 [PubMed PMID: 24052039]
Level 1 (high-level) evidenceQuaggin SE, Kreidberg JA. Development of the renal glomerulus: good neighbors and good fences. Development (Cambridge, England). 2008 Feb:135(4):609-20. doi: 10.1242/dev.001081. Epub 2008 Jan 9 [PubMed PMID: 18184729]
Level 3 (low-level) evidenceHaraldsson B, Nyström J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiological reviews. 2008 Apr:88(2):451-87. doi: 10.1152/physrev.00055.2006. Epub [PubMed PMID: 18391170]
Level 3 (low-level) evidenceScott RP, Quaggin SE. Review series: The cell biology of renal filtration. The Journal of cell biology. 2015 Apr 27:209(2):199-210. doi: 10.1083/jcb.201410017. Epub [PubMed PMID: 25918223]
White KE. Research into the structure of the kidney glomerulus--making it count. Micron (Oxford, England : 1993). 2012 Oct:43(10):1001-9. doi: 10.1016/j.micron.2012.04.013. Epub 2012 May 2 [PubMed PMID: 22607953]
Level 3 (low-level) evidenceDavies M. The mesangial cell: a tissue culture view. Kidney international. 1994 Feb:45(2):320-7 [PubMed PMID: 8164415]
Level 3 (low-level) evidenceMenè P, Cinotti GA. Paracrine and autocrine functions of glomerular mesangial cells. Journal of endocrinological investigation. 1989 Jul-Aug:12(7):497-509 [PubMed PMID: 2571630]
Level 3 (low-level) evidenceGerl K, Miquerol L, Todorov VT, Hugo CP, Adams RH, Kurtz A, Kurt B. Inducible glomerular erythropoietin production in the adult kidney. Kidney international. 2015 Dec:88(6):1345-1355. doi: 10.1038/ki.2015.274. Epub 2015 Sep 23 [PubMed PMID: 26398496]
Eckardt KU. Erythropoietin production in liver and kidneys. Current opinion in nephrology and hypertension. 1996 Jan:5(1):28-34 [PubMed PMID: 8834159]
Level 3 (low-level) evidenceFisher JW. Erythropoietin: physiology and pharmacology update. Experimental biology and medicine (Maywood, N.J.). 2003 Jan:228(1):1-14 [PubMed PMID: 12524467]
Level 3 (low-level) evidenceWang GL, Semenza GL. Molecular basis of hypoxia-induced erythropoietin expression. Current opinion in hematology. 1996 Mar:3(2):156-62 [PubMed PMID: 9372067]
Level 3 (low-level) evidenceSchoener B, Borger J. Erythropoietin Stimulating Agents. StatPearls. 2026 Jan:(): [PubMed PMID: 30725682]
Pavenstädt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiological reviews. 2003 Jan:83(1):253-307 [PubMed PMID: 12506131]
Level 3 (low-level) evidenceReiser J, Kriz W, Kretzler M, Mundel P. The glomerular slit diaphragm is a modified adherens junction. Journal of the American Society of Nephrology : JASN. 2000 Jan:11(1):1-8. doi: 10.1681/ASN.V1111. Epub [PubMed PMID: 10616834]
Level 3 (low-level) evidenceGreka A, Mundel P. Cell biology and pathology of podocytes. Annual review of physiology. 2012:74():299-323. doi: 10.1146/annurev-physiol-020911-153238. Epub 2011 Nov 4 [PubMed PMID: 22054238]
Level 3 (low-level) evidenceFaul C, Asanuma K, Yanagida-Asanuma E, Kim K, Mundel P. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends in cell biology. 2007 Sep:17(9):428-37 [PubMed PMID: 17804239]
Level 3 (low-level) evidenceDeen WM, Lazzara MJ, Myers BD. Structural determinants of glomerular permeability. American journal of physiology. Renal physiology. 2001 Oct:281(4):F579-96 [PubMed PMID: 11553505]
Level 3 (low-level) evidenceFiorentino M, Bolignano D, Tesar V, Pisano A, Van Biesen W, D'Arrigo G, Tripepi G, Gesualdo L, ERA-EDTA Immunonephrology Working Group. Renal Biopsy in 2015--From Epidemiology to Evidence-Based Indications. American journal of nephrology. 2016:43(1):1-19. doi: 10.1159/000444026. Epub 2016 Feb 5 [PubMed PMID: 26844777]
Walker PD. The renal biopsy. Archives of pathology & laboratory medicine. 2009 Feb:133(2):181-8 [PubMed PMID: 19195962]
Kitterer D, Gürzing K, Segerer S, Alscher MD, Amann K, Braun N, Latus J. Diagnostic impact of percutaneous renal biopsy. Clinical nephrology. 2015 Dec:84(6):311-22. doi: 10.5414/CN108591. Epub [PubMed PMID: 26396098]
Tapia C, Bashir K. Nephrotic Syndrome. StatPearls. 2026 Jan:(): [PubMed PMID: 29262216]
Vaziri ND. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. Kidney international. 2016 Jul:90(1):41-52. doi: 10.1016/j.kint.2016.02.026. Epub 2016 Apr 26 [PubMed PMID: 27165836]
Agrawal S, Zaritsky JJ, Fornoni A, Smoyer WE. Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nature reviews. Nephrology. 2018 Jan:14(1):57-70. doi: 10.1038/nrneph.2017.155. Epub 2017 Nov 27 [PubMed PMID: 29176657]
Raza A, Aggarwal S. Membranous Glomerulonephritis (Archived). StatPearls. 2026 Jan:(): [PubMed PMID: 29763040]
Rout P, Jialal I. Diabetic Nephropathy. StatPearls. 2026 Jan:(): [PubMed PMID: 30480939]
Rout P, Hashmi MF, Baradhi KM. Focal Segmental Glomerulosclerosis. StatPearls. 2026 Jan:(): [PubMed PMID: 30335305]
Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal Change Disease. Clinical journal of the American Society of Nephrology : CJASN. 2017 Feb 7:12(2):332-345. doi: 10.2215/CJN.05000516. Epub 2016 Dec 9 [PubMed PMID: 27940460]